Encompass Health (NYSE:EHC) EVP John Patrick Darby Sells 8,906 Shares

Encompass Health Corporation (NYSE:EHC) EVP John Patrick Darby sold 8,906 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the sale, the executive vice president directly owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Encompass Health Stock Performance

Shares of NYSE:EHC traded down $1.50 on Tuesday, reaching $124.31. 572,895 shares of the company’s stock were exchanged, compared to its average volume of 1,080,474. The company has a quick ratio of 1.17, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The business’s 50-day moving average is $107.37 and its two-hundred day moving average is $104.81. The firm has a market capitalization of $12.33 billion, a price-to-earnings ratio of 20.28, a PEG ratio of 2.52 and a beta of 0.72.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. During the same quarter in the previous year, the firm posted $1.40 EPS. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, equities research analysts forecast that Encompass Health Corporation will post 6.07 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a dividend of $0.21 per share. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. Encompass Health’s payout ratio is 12.38%.

Wall Street Analysts Forecast Growth

EHC has been the subject of a number of research reports. Wall Street Zen cut shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings lowered Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. Truist Financial lifted their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday. TD Cowen upped their target price on Encompass Health from $125.00 to $140.00 and gave the company a “buy” rating in a report on Monday. Finally, UBS Group boosted their price objective on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Encompass Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $148.71.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. boosted its position in Encompass Health by 3,059,159.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after purchasing an additional 3,793,358 shares during the last quarter. AlphaCore Capital LLC purchased a new stake in shares of Encompass Health during the 4th quarter worth about $4,881,000. Systematic Financial Management LP lifted its holdings in shares of Encompass Health by 3.6% during the 4th quarter. Systematic Financial Management LP now owns 440,752 shares of the company’s stock valued at $46,782,000 after buying an additional 15,462 shares during the last quarter. Asset Management One Co. Ltd. grew its stake in shares of Encompass Health by 128.7% in the 4th quarter. Asset Management One Co. Ltd. now owns 129,205 shares of the company’s stock valued at $13,790,000 after buying an additional 72,703 shares in the last quarter. Finally, Trillium Asset Management LLC increased its holdings in Encompass Health by 5.7% in the fourth quarter. Trillium Asset Management LLC now owns 217,734 shares of the company’s stock worth $23,424,000 after buying an additional 11,793 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.